Pure Global
NCT05295797

The Positively Dance Pilot Program for Women Living With HIV

The Positively Dance Pilot Program: Examining the Feasibility of a Peer Research Associate-Led Dance Program for Women Living With HIV
University of British Columbia·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Human Immunodeficiency Virus
Drug/Device/Intervention
Dance Program
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of British Columbia
Location
Vancouver, Canada
Timeline & enrollment
Phase
N/A
Start date
May 01, 2022
End date
Feb 01, 2023
Enrollment
30 participants
Primary outcome

Proportion of women who accept the invitation to participate in the research study,Number of women who initially participate in the intervention,Proportion of women who participate in the dance classes, even after the active data collection phase is completed,Acceptability and feasibility of the selected procedures (e.g. blood draws, questionnaires) by determining numbers who attend these sessions and complete the questionnaires,Adverse events that may occur during the trial,Continued participation of the peer dance instructors,Individual semi-structured interviews asking participants their perceptions of and experiences with the program

Summary

The Positively Dance study involves the assessment of the accessibility and feasibility of a
 12-week randomized aerobic dance pilot program that will provide women living with HIV with
 the opportunity to take part in dance classes with women living with HIV as the dance
 instructors.

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesAsymptomatic human immunodeficiency virus [HIV] infection status
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05295797
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05295797 through Pure Global AI's free database. This phase not specified trial is sponsored by University of British Columbia and is currently Recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.